- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Nov 5, 2025 | 117.11M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 117.7M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 116.98M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 118.73M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 118.92M sh |
| Stock Repurchased | Q2 2026 · Sep 30, 2025 | $171.2K |
| Stock Repurchased | Q2 2026 · Sep 30, 2024 | $460.66K |
| Capex | Q2 2026 · Sep 30, 2025 | $1.59M |
| Capex restated | Q2 2026 · Sep 30, 2024 | $2.05M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $65.67M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $30.23M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $235.42M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $222.51M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $222.03M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $325.57M |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | $342.49M |
| Stockholders Equity | Q2 2026 · Mar 31, 2024 | $358.05M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $22.73M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $62.09M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $34.86M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $75.3M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $78.3M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $72.15M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $270.27M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $297.33M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | $0.01 |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$0.06 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | −$0.11 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | −$0.24 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | $0.01 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$0.06 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | −$0.11 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | −$0.24 |
| Net Income | Q2 2026 · Sep 30, 2025 | $1.4M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$5.05M |
| Net Income | Q2 2026 · Jun 30, 2025 | −$6.46M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$12.43M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$27.19M |
| Net Income | Q2 2026 · Jun 30, 2024 | −$14.76M |
| Operating Income | Q2 2026 · Sep 30, 2025 | $707.02K |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$5.3M |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | −$6.03M |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | −$12.26M |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $10.44M |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $20.78M |
| Gross Profit restated | Q2 2026 · Sep 30, 2024 | $10.41M |
| Gross Profit restated | Q2 2026 · Sep 30, 2024 | $20.95M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $1.54M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $3.07M |
| Cost Of Revenue restated | Q2 2026 · Sep 30, 2024 | $1.57M |
| Cost Of Revenue restated | Q2 2026 · Sep 30, 2024 | $3.31M |
| Revenue | Q2 2026 · Sep 30, 2025 | $11.98M |
| Revenue | Q2 2026 · Sep 30, 2025 | $23.84M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $11.98M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $24.27M |